Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Aug 16, 2022; 10(23): 8124-8132
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8124
Table 4 Clinical characteristics and analysis of factor affecting mortality in group A, n = 13
Variables
No of cases (%)
P value
Odd ratio (95%CI)
Management
Non-operative5 (38.5)
Operation8 (61.5)
Mortality, overall10/13 (76.9)
Mortality in
Non-operative5/5 (100)
Operative5/8 (62.5)0.2310.625 (0.365-1.069)
Pneumothorax (+)6/6 (100)
Pneumothorax (-)4/7 (57.1)0.0671.750 (0.921-3.324)
PPHN (+)6/7 (85.7)
PPHN (-)4/6 (66.7)0.4163.0 (0.199-45.244)
RDS (+)9/11 (81.8)
RDS (-)1/2 (50.0)0.3264.5 (0.190-106.8)
HFOV (+)4/5 (80.0)
HFOV (-)6/8 (75.0)0.9121.333 (0.088-20.108)
Vasopressor (+)9/11 (81.8)
Vasopressor (-)1/2 (50.0)0.3264.5 (0.190-106.823)
CPR (+)3/3 (100)
CPR (-)7/10 (70.0)0.2791.429 (0.952-2.143)
Thrombocytopenia (+)7/8 (87.5)
Thrombocytopenia (-)3/5 (60.0)0.514.667 (0.197-73.384)
Full-term 1/3 (33.3)
Preterm 9/10 (90.0)0.04118.0 (0.758-427.291)